Dr. Hymes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-5196Fax+1 212-731-5540
Summary
- Dr. Kenneth Hymes is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including NYU Langone Hospitals, NYU Langone Orthopedic Hospital, and NYC Health + Hospitals / Bellevue. He received his medical degree from State University of New York Upstate Medical University and has been in practice 42 years. He specializes in cutaneous lymphoma, hiv/aids related, and hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and bone marrow transplantation.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1978 - 1981
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1978
SUNY Upstate Medical UniversityClass of 1975
Certifications & Licensure
NY State Medical License 1978 - 2025
PA State Medical License 1981 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2007, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsMultimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, Angelina Seffens, Dean David George
Blood. 2021-10-21 - 18 citationsImpaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL PatientsCatherine Diefenbach, Jessica Caro, Akiko Koide, Michael L. Grossbard, Judith D. Goldberg
Medrxiv. 2021-06-03 - 18 citationsMicrobial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphomaCatherine Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits
Blood Advances. 2021-03-09
Abstracts/Posters
- Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCLKenneth B. Hymes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)Kenneth B. Hymes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
